Spero Therapeutics Inc (NASDAQ:SPRO)

13.16
Delayed Data
As of Apr 19
 0.00 / 0.00%
Today’s Change
9.66
Today|||52-Week Range
19.00
+12.00%
Year-to-Date
No recent news for Spero Therapeutics Inc.

Today’s Trading

Previous close13.16
Today’s open13.05
Day’s range12.99 - 13.53
Volume23,466
Average volume (3 months)43,399
Market cap$172.4M
Data as of 4:00pm ET, 04/19/2018

Growth & Valuation

Earnings growth (last year)-122.89%
Earnings growth (this year)--
Earnings growth (next 5 years)+17.11%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book--

Competitors

No competitors data available.

Financials

Next reporting dateMay 30, 2018
EPS forecast (this quarter)-$1.63
Annual revenue (last year)$335.0K
Annual profit (last year)-$25.5M
Net profit margin-7,609.25%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
President, Chief Executive Officer &
Director
Ankit A. Mahadevia
Chief Operating Officer
Cristina Larkin
Corporate headquarters
Cambridge, Massachusetts

Forecasts